LAST UPDATED
April 15, 2024
Clinicaltrials.gov ID
EudraCT ID
EudraCT ID
A Phase 1/2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-X19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma (ZUMA-4) (ZUMA-4)
The primary objectives of this study are to evaluate the safety and efficacy of brexucabtagene autoleucel (KTE-X19) in pediatric and adolescent participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL) or relapsed or refractory (r/r) B-cell non-Hodgkin lymphoma (NHL). As of October 2022, no further patients with acute B-cell Acute Lymphoblastic Leukemia (ALL) will be asked to join the study. The study remains open for recruitment for patients that have B-cell Non Hodgkin Lymphoma (NHL).
View MoreAge
0 - 21 Years
Sex
All
Healthy Volunteers
No
Medical Condition
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Gender
N/A
Date
February 2016 - December 2025
Study Type
Interventional
Study Phase
Phase 1, Phase 2
Product
Brexucabtagene Autoleucel (KTE-X19), Fludarabine, Cyclophosphamide
Duarte, California, United States, 91010
Los Angeles, California, United States, 90027
Orange, California, United States, 92868
San Francisco, California, United States, 94158
Aurora, Colorado, United States, 80045
Miami, Florida, United States, 33136
Honolulu, Hawaii, United States, 96826
Chicago, Illinois, United States, 60611
Chicago, Illinois, United States, 60637
Baltimore, Maryland, United States, 21287
Minneapolis, Minnesota, United States, 55404
Rochester, Minnesota, United States, 55902
New York, New York, United States, 10032
Rochester, New York, United States, 14642
Cincinnati, Ohio, United States, 45229
Philadelphia, Pennsylvania, United States, 19104
Nashville, Tennessee, United States, 37232
Houston, Texas, United States, 77030
Houston, Texas, United States, 77030
Charlottesville, Virginia, United States, 22908
Milwaukee, Wisconsin, United States, 53226
Gent, Belgium, 9000
Toronto, Canada, M5G 1X8
Brno, Czechia, 625 00
Bordeaux, France, 33 000
Lyon, France, 69373
Marseille Cedex 5, France, 13385
Paris Cedex 19, France, 75935
Hamburg, Germany, 20246
Munich, Germany, 80337
Rome, Italy, 00165
Utrecht, Netherlands, 3508
Bydgoszcz, Poland, 85-094
Wroclaw, Poland, 50-556
Barcelona, Spain, 08950
Madrid, Spain, 28046
Stockholm, Sweden, SE-141 86
Share Trial